244 related articles for article (PubMed ID: 18777215)
1. The treatment of childhood Hodgkin lymphoma: improved survival in a developing country.
Büyükpamukçu M; Varan A; Akyüz C; Atahan L; Ozyar E; Kale G; Köksal Y; Kutluk T
Acta Oncol; 2009; 48(1):44-51. PubMed ID: 18777215
[TBL] [Abstract][Full Text] [Related]
2. Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.
Koumarianou AA; Xiros N; Papageorgiou E; Pectasides D; Economopoulos T
Anticancer Res; 2007; 27(2):1191-7. PubMed ID: 17465262
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and treatment outcome in childhood Hodgkin disease.
Oguz A; Karadeniz C; Okur FV; Citak EC; Pinarli FG; Bora H; Akyurek N
Pediatr Blood Cancer; 2005 Oct; 45(5):670-5. PubMed ID: 16007600
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center.
Karadeniz C; Oguz A; Citak EC; Uluoglu O; Okur V; Demirci S; Okur A; Aksakal N
Pediatr Hematol Oncol; 2007 Sep; 24(6):417-30. PubMed ID: 17710659
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.
Wirth A; Yuen K; Barton M; Roos D; Gogna K; Pratt G; Macleod C; Bydder S; Morgan G; Christie D
Cancer; 2005 Sep; 104(6):1221-9. PubMed ID: 16094666
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease in childhood: treatment modalities, outcome and epidemiological aspects. The Northern Israel Cancer Center experience.
Rosenthal J; Ben Arush MW; Kuten A; Ben Arie J; Ben Shahar M; Robinson E
Am J Pediatr Hematol Oncol; 1994 May; 16(2):138-42. PubMed ID: 8166366
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin disease in ataxia-telangiectasia patients with poor outcomes.
Sandoval C; Swift M
Med Pediatr Oncol; 2003 Mar; 40(3):162-6. PubMed ID: 12518345
[TBL] [Abstract][Full Text] [Related]
9. The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component.
Abuzetun JY; Loberiza F; Vose J; Bierman P; Bociek RG; Enke C; Bast M; Weisenburger D; Armitage JO;
Br J Haematol; 2009 Feb; 144(4):531-7. PubMed ID: 19055670
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological study of Hodgkin's lymphoma in a cancer center in Taiwan.
Lee MY; Tan TD; Feng AC
Clin Lab Haematol; 2005 Dec; 27(6):379-83. PubMed ID: 16307539
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
[TBL] [Abstract][Full Text] [Related]
12. Developing anticancer chemotherapy services in a developing country: Hodgkin lymphoma experience.
Chandra J; Naithani R; Singh V; Saxena YK; Sharma M; Pemde H
Pediatr Blood Cancer; 2008 Oct; 51(4):485-8. PubMed ID: 18636462
[TBL] [Abstract][Full Text] [Related]
13. [Lymphomas in adolescents: are childhood lymphoma therapy protocols suitable for this patient group?].
Bence Z; Kovács G; Jakab Z; Csóka M; Müller J
Magy Onkol; 2008 Dec; 52(4):357-62. PubMed ID: 19068463
[TBL] [Abstract][Full Text] [Related]
14. [Hodgkin's disease under twenty years of age--clinicopathological study].
Ishida Y; Mukai K; Takayama J; Ohira M; Shimoyama M
Rinsho Ketsueki; 1989 Apr; 30(4):452-9. PubMed ID: 2769968
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin lymphoma in Tyrol-a population-based study.
Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
[TBL] [Abstract][Full Text] [Related]
16. Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma.
Mauz-Körholz C; Gorde-Grosjean S; Hasenclever D; Shankar A; Dörffel W; Wallace WH; Schellong G; Robert A; Körholz D; Oberlin O; Hall GW; Landman-Parker J
Cancer; 2007 Jul; 110(1):179-85. PubMed ID: 17526010
[TBL] [Abstract][Full Text] [Related]
17. Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study.
Maruyama D; Watanabe T; Beppu Y; Kobayashi Y; Kim SW; Tanimoto K; Makimoto A; Kagami Y; Terauchi T; Matsuno Y; Tobinai K
Jpn J Clin Oncol; 2007 Mar; 37(3):216-23. PubMed ID: 17472971
[TBL] [Abstract][Full Text] [Related]
18. [Hodgkin's disease in childhood--northern Israel cancer center experience, 1971-1990].
Ben-Arush M; Rosenthal J; Peretz-Nahum M; Kuten A; Ben-Arie J; Ben Shahar B; Yarom J; Robinson E
Harefuah; 1993 Nov; 125(10):333-7, 392. PubMed ID: 8253397
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's lymphoma--long-term outcome: an experience from a tertiary care cancer center in North India.
Ganesan P; Kumar L; Raina V; Sharma A; Bakhshi S; Sreenivas V; Vijayaraghavan M; Thulkar S
Ann Hematol; 2011 Oct; 90(10):1153-60. PubMed ID: 21625999
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida.
Chera BS; Olivier K; Morris CG; Lynch JW; Mendenhall NP
Am J Clin Oncol; 2007 Dec; 30(6):601-6. PubMed ID: 18091054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]